YHLO_YHLO News

YHLO Newest IVDR Certificate Extended to 72 Products

Time Posted : 2022-08-22

In August 2022, YHLO received the newest IVDR Certificate from BSI, one of the most reputable notified bodies for medical device CE certifications.

YHLO innovative iFlash series showcased at the 2022 AACC Expo

Time Posted : 2022-07-29

YHLO Medical Device Industrial Park in Hunan Start Construction

Time Posted : 2022-07-25

YHLO COVID-19 Rapid Test Effectively Detect More Mutant Strains

Time Posted : 2022-07-12

Peking University—YHLO Joint Lab Achieved Another Great Result

Time Posted : 2022-07-05

Global registration overview of YHLO diagnostic kits for Novel Coronavirus COVID-19 Antigen/Antibody

Time Posted : 2022-06-21

YHLO showcased at 13th International Congress on Autoimmunity

Time Posted : 2022-06-15

From 10-13 June 2022, YHLO was grandly showcased at the 13th International Congress on Autoimmunity in Athens, Greece

Meet YHLO at 13th International Autoimmunity Congress in Greece

Time Posted : 2022-05-18

...

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA POCT ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +